Tirzepatide: as the comparator
21 studies: what is tested is compared with it. Page 1 of 1. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.
- A Clinical Study to Evaluate the Effects of Enicepatide Versus Tirzepatide in Participants With Type 2 Diabetes and Inadequate Blood Sugar Control on Oral Glucose-Lowering MedicationsNot yet recruitingNCT07889648Phase 3Report a problem
- A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or ObesityRecruitingNCT07845500Phase 3Report a problem
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC35 Injection in Participants With Obesity or OverweightRecruitingNCT07842640Phase 1Report a problem
- A Study of SYH2069 Injection in Participants With T2DM Not Controlled With Diet/Exercise Alone or MetforminNot yet recruitingNCT07796477Phase 2Report a problem
- AI-Assisted Lifestyle Intervention Versus Tirzepatide for Obesity and Newly Diagnosed Type 2 DiabetesRecruitingNCT07697391Phase 4Report a problem
- AI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN)Not yet recruitingNCT07555730Phase 4Report a problem
- Efficacy and Safety of HDM1005 Compared to Tirzepatide in Obese Adults Without DiabetesRecruitingNCT07521631Phase 2Report a problem
- A Study to Evaluate ALN-2232 in Participants With ObesityRecruitingNCT07463846Phase 1/2Report a problem
- Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver DiseaseRecruitingNCT07058155Phase 4Report a problem
- Metabolic Surgery for Atrial Fibrillation EliminationNot yet recruitingNCT07027969Phase 4Report a problem
- Fibrosis Lessens After Metabolic SurgeryRecruitingNCT06374875Phase 4Report a problem
- Tolerance and Pharmacokinetic/Pharmacokinetic Study of IBI362 15mg in Patients With Moderate to Severe ObesityActive, not recruitingNCT07000955Phase 1/2Report a problem
- A Study of BGM0504 in Participants With ObesityCompletedNCT06911203Phase 2Report a problem
- Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight ParticipantsCompletedNCT06737042Phase 2Report a problem
- A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have ObesityActive, not recruitingNCT06662383Phase 3Report a problem
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or BothCompletedNCT06534411Phase 3Report a problem
- A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose WeightCompletedNCT06326060Phase 2Report a problem
- A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 DiabetesCompletedNCT06326047Phase 2Report a problem
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 InhibitorCompletedNCT06221969Phase 3Report a problem
- A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose WeightCompletedNCT06131437Phase 3Report a problem
- Gastric Sleeve-Induced Weight Loss on Shortness of Breath in ObesityWithdrawnNCT05812183Phase 4Report a problem